Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • dsroyal91 dsroyal91 Oct 10, 2012 5:56 PM Flag

    ACTC filed for up listing. I wonder what the initial comments that were given? Must be good!

    Company ended 2012 Q2 with $10 million cash on hand
    • $35 million more available under equity line
    • Virtually debt-free
    • Received shareholder approval for reverse split
    • Filed application for NASDAQ uplisting and have initial comments
    Other 2012 Milestones (so far)
    • IRB approvals from Wills Eye Institute, Bascom Palmer Eye Hospital and
    Massachusetts Eye & Ear
    • Initiated Europe’s first human ESC-derived transplant at Moorfields Eye Hospital
    • Published first report of hESC-derived cells transplanted into humans in top
    medical journal, The Lancet.
    • Completed Dose Cohort 1 of patients in both U.S. trials;
    • Dosed first SMD and dry AMD patients in 100,000 cell cohorts – no AE’s observed

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACTC
0.00(0.00%)